McKesson recognized for its 'At Your Service' program
McKesson Patient Relationship Solutions (MPRS) was a finalist in the eyeforpharma Philadelphia Awards 2016. Read More »
McKesson Patient Relationship Solutions (MPRS) was a finalist in the eyeforpharma Philadelphia Awards 2016. Read More »
SSM Health to take over 27 of Walgreens' retail health clinics in the St. Louis area. Read More »
Sisu Janani Seva "mHealth" allows health care workers to monitor pregnant women and babies. Read More »
The annual spring conference featured solutions to the changing landscape in health care delivery systems. Read More »
Walgreens makes lifesaving medication available at more than 120 pharmacies in Pennsylvania. Read More »
Various states have enacted or are considering legislation limiting the circumstances under which maximum allowable cost programs (MACs) may be used, a decision that one expert says could result in increased pharmaceutical spending that in turn increases the cost of pharmaceutical coverage. Read More »
The pharmaceutical wholesale business was sold to 36.6, a Russian health and beauty retailer. Read More »
Amgen recently announced its win against Sanofi and Regeneron Pharmaceuticals. Read More »
McKesson recently announced that it has been awarded a $139 million, five-year contract from the Department of Defense and the Defense Health Agency for its patient engagement and interoperable secure messaging solution, RelayHealth. Read More »
One pharmaceutical company executive stated that the challenges retail and outpatient pharmacies face in regards to the reimbursement and regulatory environment can be solved by technology. Read More »
Blue Cross and Blue Shield of Illinois (BCBSIL) and Illinois Cancer Specialists (ICS) have announced the very first oncology intensive medical home (IMH) pilot program in Illinois. Read More »
Amgen and UCB have announced the results of the Phase 3 trial for romosozumab. Read More »
Walgreens has confirmed that it will be returning as the second annual Red Nose Day’s exclusive retail partner on May 26. Read More »
McKesson announced this week that it has launched its disaster recovery service that will help health care organizations uphold their mission-critical capabilities when disasters strike. Read More »
Walgreens Boots Alliance has announced that it has exercised warrants for the purchase of 22,696,912 common stock shares of AmerisourceBergen Corp. for a total payment of $1.17 billion. Read More »
Amgen has announced that it will present 19 abstracts associated with its cardiovascular portfolio that will include new data from the evaluation of Repatha (evolocumab) at the American College of Cardiology’s 65th Annual Scientific Session (ACC 16). Read More »
Amgen and UCB have announced positive high quality results from the pivotal Phase 3 placebo-controlled study evaluatIng the efficiency and safety of romosozumab in treating men with osteoporosis (BRIDGE) trial. Read More »
Astellas Pharm Inc. announced this week that it has named a Nadeshiko Brand component by the Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange (TSE) for its excellence in the promotion and involvement of women in the workplace. Read More »
Orexigen Therapeutics and Takeda Pharmaceuticals U.S.A., a subsidiary of Takeda Pharmaceutical Co., announced earlier this week that they have agreed on terms to terminate the Amended and Restated Collaboration Agreement for CONTRAVE (naltrexone HCI/bupropion HCI). All rights to the medication will belong to Orexigen. Read More »
The Takeda Pharmaceutical Co. and Frazier Healthcare Partners recently launched Outpost Medicine, a new company in the biopharmaceutical field that will focus on developing new treatment options for urologic and gynecologic diseases and disorders. Read More »